Search For "pharmaceutical company"
Glenmark introduces NINDANIB (Nintedanib) and is amongst the first to laun
Updated : 5 years, 5 months ago IST
Mumbai (Maharashtra) [India], October 14 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today launched NINDANIB (Nintedanib 100 and 150 mg capsules) for the treatment of pulmonary fibrosis in India.
Read More
Eli Lilly pauses COVID-19 treatment trial for Safety Reasons
Updated : 5 years, 5 months ago IST
Washington [US], October 14 (ANI/Sputnik): The US pharmaceutical company Eli Lilly's late-stage trial of its leading monoclonal antibody treatment for the novel coronavirus has been paused by health regulators over potential safety concerns, CNBC reported.
Read More
Johnson & Johnson pauses vaccine trial after volunteer falls ill
Updated : 5 years, 5 months ago IST
Washington [US], October 13 (ANI): Pharmaceutical company Johnson & Johnson announced on Monday that it has paused the advance clinical trial, ENSEMBLE, of one of its vaccines after an unexplained illness was found in one of the volunteers.
Read More
Harnessing nature's healing powers innovative herbal solutions to your hea
Updated : 5 years, 5 months ago IST
New Delhi [India], October 5 (ANI/BusinessWire India): The incessant pursuit of development has accelerated life's pace. As a result, health concerns have moved down our priority list.
Read More
Dr Reddy's joins Science Based Targets initiative (SBTi), sets 2030 GHG em
Updated : 5 years, 5 months ago IST
Hyderabad (Telangana) [India], October 5 (ANI): Dr Reddy's Laboratories has joined the Science Based Targets initiative's (SBTi) business ambition for 1.5 degrees celsius, becoming the first Indian and third Asian pharmaceutical company to minimise environmental impact.
Read More
First Russian volunteers inoculated with China's COVID-19 vaccine
Updated : 5 years, 5 months ago IST
Moscow [Russia], September 21 (ANI/Sputnik): Russian pharmaceutical company Petrovax launched phase 3 clinical trials of the Chinese Covid-19 vaccine candidate, CanSino Biologics Ad5-nCoV, on the first group of Russian volunteers in Moscow, the company said on Monday.
Read More
AstraZeneca CEO says COVID-19 vaccine may be ready by end of year despite
Updated : 5 years, 6 months ago IST
London [UK], September 10 (ANI/Sputnik): AstraZeneca CEO Pascal Soriot on Wednesday expressed hopes that a vaccine against the novel coronavirus developed by the pharmaceutical company would be ready by the end of 2020 or early 2021, despite having to pause clinical trials.
Read More
Canada scraps Covid-19 vaccine trial with Chinese pharma company
Updated : 5 years, 6 months ago IST
Beijing [China], Aug 30 (ANI): Canada has decided to cancel a coronavirus vaccine development agreement with the Chinese pharmaceutical company CanSino due to delay in the shipping of drugs.
Read More
UK's AstraZeneca begins human trial of COVID-19 treatment using monoclonal
Updated : 5 years, 6 months ago IST
London [UK], Aug 25 (ANI/Sputnik): UK-based pharmaceutical company AstraZeneca announced on Tuesday that it had begun the human trial of a new treatment for COVID-19 using a combination of two monoclonal antibodies.
Read More
Glenmark appoints Dipankar Bhattacharjee to its Board of Directors
Updated : 5 years, 7 months ago IST
Mumbai (Maharashtra) [India], Aug 17 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, announced the appointment of Dipankar Bhattacharjee as Independent Non-Executive Director on the Board of the organization for a period of five years wit
Read More
Fusion Health Care launches COVID-19 drug Favipiravir and an immunity boos
Updated : 5 years, 7 months ago IST
Hyderabad (Telangana) [India], Aug 17 (ANI/BusinessWire India): Fusion Health Care Pvt Ltd, a leading innovative pharmaceutical company based at Hyderabad, has announced the launch of its Favipiravir drug under the brand name XARAVIR, for the treatment of mild to moderate COVID-19 cases.
Read More
US, Moderna in deal for 100 million doses of coronavirus vaccine: Trump
Updated : 5 years, 7 months ago IST
Washington [US], August 12 (ANI): The United States has made an agreement with the pharmaceutical company Moderna to deliver 100 million doses of their novel coronavirus vaccine once it becomes available, said President Donald Trump on Tuesday.
Read More